ImmunoIVD, Early Detection for Life-Saving interventions
Brisbane, Australia – July 31, 2025
ImmunoIVD is a market-leading provider of SCID newborn screening assays in Europe. Their Spot-it™ Newborn Screening Assays includes TREC, KREC & SMN1 Screening kits, which are in vitro diagnostic kits intended to screen for severe combined immunodeficiency (SCID), agammaglobulinemia (XLA) and Spinal Muscular Atrophy (SMA) in newborns. These kits can be provided separately or collectively for simultaneous screening.
The Spot-it™ Newborn Screening Assays are available in the following products:
An in vitro diagnostic (IVD) kit intended for newborn screening for severe combined immunodeficiency (SCID).
An in vitro diagnostic (IVD) kit intended for newborn screening for severe combined immunodeficiency (SCID) and agammaglobulinemia (XLA).
An in vitro diagnostic (IVD) kit intended for newborn screening for severe combined immunodeficiency (SCID) and spinal muscular atrophy (SMA) in newborns.
An in vitro diagnostic (IVD) kit intended for newborn screening for severe combined immunodeficiency (SCID), agammaglobulinemia (XLA), and spinal muscular atrophy (SMA) in newborns.
The Spot-it™ Screening Solutions assays are already pre-filled, which requires minimal hands-on time, and eliminates the need for liquid-handling equipment and a separate clean room for MasterMix preparation.
Their reliable and sensitive qPCR-based assays can provide results from Dried Blood Spot within three hours. Used in national screening programs in European countries since 2016, ImmunoIVD has established itself as the market-leading provider of SCID newborn screening assays within Europe.
For more information about the partnership and product offerings, please use the links below:
About ImmunoIVD:
ImmunoIVD is committed to providing reliable, accessible and high-quality assays for newborn screening for SCID, SMA, and XLA, improving the quality of life of babies and their parents. Their assays are recognized for their reliability and easy-to-use workflow, that requires minimal laboratory space and equipment investment.
About Abacus dx:
Abacus dx is a leading distributor of in-vitro diagnostic and scientific solutions in Australia and New Zealand. With a strong focus on customer service and support, Abacus dx provides innovative solutions that enhance laboratory operations and patient care.
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
